Highlights
1 patent
About
Therapeutic Antibodies for the Treatment of Cancer
Trojan Bio is a preclinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of cancers. The company’s Trojan antibodies integrate viral peptides to efficiently activate the immune system for cancer eradication.
Trojan Bio specific antibody is composed of 2 modules - Cancer targeting module and a Viral immunity activation module. It targets cancer cells and label them as virally infected cells. The company is harnessing the powerful anti-viral immunity to fight a variety of cancers.
Identity
| Name | Trojan Bio |
|---|---|
| Slug | trojan-bio |
| Type / kind | startup |
| Source _id | slPvoeOaBCkwInv9KCZBmNXoUYfmUlG6DbFo7QFHxSFO1BTBqEJ53T |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Yavne |
| HQ address | HaKishon St 18, Yavne, Israel |
Web & social
| Website | https://www.trojan-bio.com/ |
|---|---|
| https://www.linkedin.com/company/82642561 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
cancerclinicspharmaceuticalsimmuno-theraphycancer-therapy
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}